Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | AMGN | VRTX | BMY | GILD |
| Company | Arena Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 99.97 | 275.01 | 458.06 | 58.84 | 93.50 |
| High | 100.00 | 275.36 | 465.91 | 59.28 | 94.22 |
| Low | 99.97 | 271.48 | 456.86 | 58.69 | 92.37 |
| Last | 99.99 | 272.70 | 461.33 | 58.76 | 92.36 |
| Change | +0.06 | -1.63 | +1.41 | -0.08 | -1.03 |
| % Change | +0.06% | -0.59% | +0.31% | -0.14% | -1.10% |
| Volume | 5,718,500 | 1,270,688 | 499,203 | 2,358,487 | 1,322,254 |
| 20-Day Average Volume | 1,676,465 | 4,536,599 | 1,345,729 | 10,851,904 | 7,159,073 |
| Previous Close | 99.93 | 274.33 | 459.92 | 58.84 | 93.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 288.85 | 469.50 | 58.34 | 91.83 |
| 20-Day Raw Stochastic | 99.86% | 21.74% | 22.20% | 68.92% | 49.45% |
| 20-Day Relative Strength | 75.07% | 31.59% | 46.29% | 59.47% | 56.44% |
| Weighted Alpha | -14.40 | -7.03 | +22.30 | +26.30 | +26.35 |
| Today's Opinion | 100% Buy | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | -3.45% since 11/29/24 | -1.39% since 11/29/24 | -0.59% since 11/29/24 | -0.17% since 11/29/24 |
| Low | 93.54 on 03/07/22 | 271.65 on 12/06/24 | 450.00 on 12/04/24 | 57.59 on 12/04/24 | 89.86 on 12/04/24 |
| High | 100.00 on 03/10/22 | 282.39 on 12/02/24 | 468.51 on 12/03/24 | 60.09 on 12/03/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | -15.13% since 11/06/24 | -6.49% since 11/06/24 | +6.49% since 11/06/24 | +0.80% since 11/06/24 |
| Low | 92.85 on 02/22/22 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 100.00 on 03/10/22 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | -14.80% since 09/06/24 | -1.36% since 09/06/24 | +20.88% since 09/06/24 | +17.40% since 09/06/24 |
| Low | 89.03 on 01/25/22 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 78.36 on 09/09/24 |
| High | 100.00 on 03/10/22 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | -10.65% since 06/06/24 | -4.92% since 06/06/24 | +44.01% since 06/06/24 | +44.75% since 06/06/24 |
| Low | 48.12 on 12/06/21 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 100.00 on 03/10/22 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 147,461,424 | 118,442,736 | 119,337,936 | 116,388,784 |
| Shares Outstanding, K | 61,659 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 50,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -616,430,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 50,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -155,610,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.55 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/04/22 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 0.00 | 49.89 | 20.67 |